Renal hemodynamics and the mediators in sepsis;Sepsi̇ste renal hemodi̇nami̇ ve medi̇yatörler

Erciyes Tip Dergisi

Volumn 24, Issue 4, 2002, Pages 202-208

  Cankurtaran, Mustafa ^a   Kiykim, Ahmet ^a  

^a NONE

Author keywords

Inflammation mediators; Kidney failure; Renal circulation; Sepsis

Indexed keywords

ADENOSINE; ANGIOTENSIN; CELL ADHESION MOLECULE; ENDOTHELIN; INTERLEUKIN 1; LEUKOTRIENE; NORADRENALIN; PLATELET DERIVED GROWTH FACTOR; PROSTACYCLIN; PROSTAGLANDIN E2; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ACUTE KIDNEY FAILURE; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MORTALITY; NEUTROPHIL; PATHOGENESIS; REPERFUSION INJURY; REVIEW; SEPSIS; THROMBOSIS;

EID: 0036975211     PISSN: 1300199X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Wardle En. Acute renal failure and multiorgan failure. Nephron 66: 380-385, 1994.
2. Bellamo R, Hallemeesch M, Cobben Dcet al. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill patients. Trans Am Soc Artif Organ 37: M322-M323, 1991.
3. Goldfarb S. Proinflammatory cytokines and sepsis. J Am Soc Nephrol 5: 228-232, 1994.
4. Hoffman J, Hartl W. Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 48: 1563-1570, 1995.
5. Heering P, Morgera S, Schmitz G, et al. Cytokine removal ond cardiovascular hemodynamics in septic patients with continuous veno-venous hemofiltration. Intensive Care Med 20: 288-296, 1997.
6. Rogiers P. Hemofiltration treatments for sepsis: is it time for controlled studies? Kidney Int 56; (Suppl 72): S99-103, 1999.
7. De Vriese A, Colardyn FA, Philippe JJ, Vanholder RC, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10: 846-853, 1999.
8. Thijs A, Thijs L. Pathogenesis of renal failure in sepsis. Kidney Int 53 (Suppl 66), S34-S37: 1998.
9. Groeneveld ABJ. Pathogenesis of acute renal failure during sepsis. Nephrol Dial Transplant 9; 47-51, 1994
10. Rangel A, Frausto M, Lonnemann G, et al. The natural history of SIRS. JAMA 273:117-123, 1993 Weber A Schweitzeger et al: The course of systemic and renal prostonoids concentrations and renal function in bovine hyperdynamic sepsis Clin Sciences 86: 599-610, 1994.
11. Rangel A, Frausto M, Lonnemann G, et al. The natural history of SIRS. JAMA 273:117-123, 1993 Weber A Schweitzeger et al: The course of systemic and renal prostonoids concentrations and renal function in bovine hyperdynamic sepsis Clin Sciences 86: 599-610, 1994.
12. Spain DA, Wilson M, Garrison N, et al. Nitric oxide synthase inhibitörs exacerbates sepsis induced renal hypoperfusion. Surgery 116:322-331, 1994.
13. Heemskerk AEJ, Huisman E, Van Lambalgen A, et al. Renal function and oxygen consumption during bacteremia and endotoxemi ain rats. Nephrol and Dialysis Trans. 12:1586-1594, 1997.
14. Heinzmann. Neutrophiles and renal failure. Am J Kidney Dis 1999; 34: 384-399.
15. Meisser A, Wang J, Dunn Mj et al. TNF alfa and lipopolysaccaharides induce apopitotic cell death in bovine glomerüler endothelial cells. Kidney Int 1999; 55: 22-37.
16. Mariona F, Laszik Z, Nadosy T et al. Production of PAF in patients with sepsis associated acut renal failure Nephrol Dia Trans 1999; 14: 1150-1157.
17. Kohan D. Role of endothelin and tumor necrozis factor in the renal response to sepsis. Nephrol and Dialysis Trans 1994; 9:73-77.
18. Jack A, Skoultz K, Rady A, et al. Tumor necrosis factor and cytokines in sepsis. Clin Infect Dis 1998; 657-662.
19. Shmuel H, Pitlik S, Drucker M, et al. Prediction of mortality in patients with bacteremia: the importance of preexisting renal insufficiency renal. Failure 2000; 22: 99-108.
20. Klahr S: Role of Arachidonic acid metabolites in acut renal failure and sepsis. Nephrol and Dialysis Trans 1999; 8:64-68.
21. Shieh P, Zhou M, Ornan Da et al. Upregulation of inducible nitricoxide synthase and nitricoxide occurs laterthan the onset of the hyperdynamic response during sepsis Shock 2000; 13: 325-329.
22. Filep JG. Role for endogenous endothelin in the regulation of plasma volume and albumin during endotoxic schock in conscious rats. Br J Pharmacol 2000; 129: 975-83.
23. Raza A. AntiTNF alpha therapies in rheumotoid arthritis, Chron's disease, sepsis and myelodisplastic syndromes. Microsc Res Tech 2000; 50: 229-235.
24. Bengston A, Redl H, Schlag G, Hogasen K, et al. AntiTNF treatment of baboons with sepsis reduces TNF-alpha, Il-6, Il-8, but not the degree of complement activation. Scand J Immunology 1998; 48: 509-514.
25. Clark MA, Plank LD, Connaly Ab et al. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis. Crit care Med 1998; 26:1650-1659.
26. Ranco C, Brendolan A, Dan M, et al. Adsorption in sepsis. Kidney Int 2000; 58 Supply 76: s148-55.
27. Hallemeesch MM. Renal aminoacid metabolism during endotoxemia in the rat. J Surg Res 2000; 92:193-200.
28. Tschaikowsky K, Sagner S, Lehnert N, et al. Endothelin in septic patients: Effects on cardiovascular and renal functionand its relationship to proinflamatory cytokines. Crit Care Med 1998;28:1854-1860.
29. Day NP, Phu NH, Mai N et al. Effects of dopamine and epinephrine infusions on renal hemodynamics in severe sepsis. Crit Care Med 2000; 28: 1353-1362.
30. Krysztopic RJ, Matheson PJ, Spain Da, et al. Lazaroid and Pentoxifyline supress sepsis induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 2000; 93: 75-81.
31. Matsukawa A, Hogaboam CM, Lukacs NW, et al. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Experimental Mol Pathol 2000; 68:77-84.
32. Bowner CJ. Vasoactive Intestinal polypeptide inhibits degranulation and changes granular. Peptides 2000; 21: 81-89.